FDA Brief

Company record

Stryker Neurovascular

0 FDA warning letters since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about Stryker Neurovascular.

Recalls

ReportedClassFirmProduct and reason
Jul 1 Class II Stryker Neurovascular
Device
INZONE DETACHMENT SYSTEM, REF: M00345100950
Embolization coil detachment system devices may experience premature battery drain causing devices to: 1) Not power on; 2) Power on with faint audible and visual indicators; 3) Be unable to detach a coil as intended, which may necessitate medical intervention if the procedure must be completed with an alternative technique.